IPM Access Principles and Strategy

Microbicides and other HIV prevention products will not be effective unless our products reach the women who need them. In deciding which product candidates to prioritize, IPM recognizes five concepts central to understanding and achieving access to microbicides:

Architecture: The network of organizations at the global, national and local levels that will support, connect and implement all microbicide access activities must be in place.

Availability: Sufficient high-quality production and supply of microbicide products, and reliable channels for distribution to meet user demand is vital.

Acceptability: A microbicide product and how it is provided need to be satisfactory to end-users (women and their sexual partners), and to gatekeepers who control and facilitate availability.

Affordability: The costs of microbicides and programs to deliver them must be affordable to purchasers, financers and end-users.

Appropriate use: Microbicides need to be used properly as part of personal and programmatic strategies to achieve the desired health outcome: preventing HIV transmission.

How IPM Supports Access:

  • Acquiring intellectual property rights for drugs in development.
  • Developing products that meet women’s needs and preferences.
  • Conducting clinical trials to international regulatory and ethical standards with strong country and community participation.
  • Interacting with African, European and US regulatory authorities, and the WHO to outline a global drug development plan for regulatory decision-making for IPM’s novel products.
  • Identifying high-quality, cost-effective manufacturing options.
  • Undertaking social and policy research to inform product introduction and use.
  • Facilitating strategic partnerships in manufacturing, distribution and marketing.
  • Developing IPM Strategic Access Plan